Musculoskeletal pain in patients with psoriasis and its influence on health-related quality of life: Results from a danish populationbased survey
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Musculoskeletal Pain in Patients with Psoriasis and its Influence on Health-related Quality of Life: Results from a Danish Populationbased Survey
Forlagets udgivne version, 456 KB, PDF-dokument
A nationwide e-based survey of patients with psoriasis was preformed to assess the pattern of musculoskeletal pain and its influence on patient-reported outcomes, including health-related quality of life and disability. A total of 561 respondents (56% of the screened psoriasis patients) reported physiciandiagnosed psoriasis and completed the questionnaire. Respondents were grouped based on the presence of musculoskeletal pain and/or diagnosed psoriatic arthritis: 81% had psoriasis without arthritis (29% pain now, 23% pain previously, 39% no pain ever), and 19% had psoriatic arthritis. Patients with psoriasis with pain now had poorer quality of life compared with patients without pain and, importantly, similar to that of patients with arthritis. Furthermore, patients with pain now/previously reported higher self-assessed severity of psoriasis and lower satisfaction with current treatment than patients without pain. Two-thirds of patients with psoriasis with pain now/previously and one-third of patients with arthritis had never been examined by a rheumatologist, demonstrating an unmet need for adequate evaluation of such patients.
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | adv00553 |
| Tidsskrift | Acta Dermato-Venereologica |
| Vol/bind | 101 |
| Udgave nummer | 9 |
| ISSN | 0001-5555 |
| DOI | |
| Status | Udgivet - 2021 |
Bibliografisk note
Funding Information:
The authors acknowledge the participating respondents who contributed to this study. The study was financially supported by research grants from Amgen, Celgene and The Danish Rheumatism Association. The Danish Rheumatism Association and The Danish Psoriasis Research Foundation have supported the work of SKF. The sponsors had no influence on study design, data analysis or manuscript preparation. Conflicts of interest. SKF received research support from Amgen/Celgene. Lene Terslev received speaker’s fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE. IJS have nothing to disclose. LS has been a paid speaker for AbbVie, Eli Lilly, Novartis, and LEO Pharma, and has been a consultant or has served on Advisory Boards with AbbVie, Janssen Cilag, Novartis, Eli Lilly, LEO Pharma, UCB, Almirall, Bristol-Myers Squibb, and Sanofi. She has served as an investigator for AbbVie, Sanofi, Janssen Cilag, Boehringer Ingelheim, Pfizer, AstraZeneca, Eli Lilly, Novartis, Regeneron, and LEO Pharma, and has received research and educational grants from Novartis, Sanofi, Bristol-Myers Squibb, Janssen Cilag, and LEO Pharma. CZ has been a scientific consultant, advisor, investigator, or speaker for Eli Lilly, Jansen Cilag, Novartis, Abbvie, Takeda, Amgen, Almirall, CSL, UCB, Regeneron, MSD, and Leo Pharma. MØ received research support, consultancy fees and/or speaker fees form AbbVie, BMS, Boehringer Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB.
Funding Information:
The authors acknowledge the participating respondents who contributed to this study. The study was financially supported by research grants fromAmgen, Celgene and The Danish Rheumatism Association. The Danish Rheumatism Association and The Danish Psoriasis Research Foundation have supported the work of SKF. The sponsors had no influence on study design, data analysis or manuscript preparation. Conflicts of interest. SKF received research support from Amgen/Celgene. Lene Terslev received speaker?s fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE.
Publisher Copyright:
© 2021, Medical Journals/Acta D-V. All rights reserved.
ID: 284407062